Jubilant Life Sciences rose 1.83% to Rs 161 at 11:32 IST on BSE after a foreign brokerage maintained its buy rating on the stock, citing attractive valuations.
Meanwhile, the BSE Sensex was down 71.69 points, or 0.25%, to 28,638.18.
On BSE, so far 91,000 shares were traded in the counter, compared with an average volume of 1.62 lakh shares in the past one quarter.
The stock hit a high of Rs 166.75 and a low of Rs 159 so far during the day. The stock hit a 52-week high of Rs 222 on 13 June 2014. The stock hit a 52-week low of Rs 116.10 on 17 December 2014.
The stock had underperformed the market over the past one month till 10 March 2015, rising 0.03% compared with 1.25% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 19.82% as against Sensex's 3.16% rise.
The small-cap company has an equity capital of Rs 15.93 crore. Face value per share is Re 1.
More From This Section
The brokerage feels that the valuations of the Jubilant Life Sciences stock are attractive, given expectations of improvement in EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margins and free cash flows. The current financial year 2014-15 is tough for the company, but the brokerage expects revival in FY 2016.
On consolidated basis, Jubilant Life Sciences reported a net loss of Rs 11.16 crore in Q3 December 2014 compared with net profit of Rs 143.43 crore in Q3 December 2013. Net sales rose 0.2% to Rs 1430.25 crore in Q3 December 2014 over Q3 December 2013.
Jubilant Life Sciences is engaged in manufacture and supply of APIs, solid dosage formulations, specialty pharmaceuticals and life science ingredients. It also provides services in contract manufacturing and drug discovery solutions. The company's strength lies in its unique offerings of pharmaceutical and life sciences products and services across the value chain. With 10 world-class manufacturing facilities in India, US and Canada and a team of about 6,100 multicultural people across the globe, the company is committed to deliver value to its customers spread across over 100 countries.
Powered by Capital Market - Live News